DOI:
10.1055/s-00034913
Phlebologie
LinksClose Window
References
Beyer-Westendorf J, Schellong SM, Gerlach H. et al.
Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial.
Lancet Haematology 2017;
4: 105-113
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.